Everpar Advisors LLC Grows Stake in Intuitive Surgical, Inc. $ISRG

Everpar Advisors LLC increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 2.0% in the 2nd quarter, according to the company in its most recent disclosure with the SEC. The fund owned 1,267 shares of the medical equipment provider’s stock after purchasing an additional 25 shares during the quarter. Everpar Advisors LLC’s holdings in Intuitive Surgical were worth $688,000 as of its most recent filing with the SEC.

Other large investors also recently bought and sold shares of the company. AlphaCore Capital LLC grew its stake in Intuitive Surgical by 4.2% during the 4th quarter. AlphaCore Capital LLC now owns 451 shares of the medical equipment provider’s stock valued at $235,000 after purchasing an additional 18 shares in the last quarter. Crown Wealth Group LLC grew its position in shares of Intuitive Surgical by 4.8% during the first quarter. Crown Wealth Group LLC now owns 440 shares of the medical equipment provider’s stock worth $218,000 after buying an additional 20 shares in the last quarter. FSM Wealth Advisors LLC increased its stake in shares of Intuitive Surgical by 3.8% in the first quarter. FSM Wealth Advisors LLC now owns 546 shares of the medical equipment provider’s stock worth $270,000 after buying an additional 20 shares during the last quarter. CFO4Life Group LLC raised its holdings in Intuitive Surgical by 4.8% in the first quarter. CFO4Life Group LLC now owns 436 shares of the medical equipment provider’s stock valued at $216,000 after acquiring an additional 20 shares in the last quarter. Finally, J. W. Coons Advisors LLC boosted its stake in Intuitive Surgical by 1.4% during the 1st quarter. J. W. Coons Advisors LLC now owns 1,497 shares of the medical equipment provider’s stock valued at $741,000 after acquiring an additional 20 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Insider Activity

In other news, EVP Myriam Curet sold 4,500 shares of the business’s stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total transaction of $2,216,160.00. Following the completion of the transaction, the executive vice president directly owned 353 shares in the company, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Gary S. Guthart sold 29,360 shares of the firm’s stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the sale, the insider owned 19,827 shares in the company, valued at approximately $9,368,059.23. This represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last 90 days, insiders have sold 45,224 shares of company stock valued at $21,716,492. Insiders own 0.70% of the company’s stock.

Intuitive Surgical Stock Performance

Intuitive Surgical stock opened at $433.99 on Tuesday. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The company has a 50-day simple moving average of $483.65 and a 200-day simple moving average of $506.85. The firm has a market capitalization of $155.58 billion, a P/E ratio of 60.53, a P/E/G ratio of 4.71 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a net margin of 28.51% and a return on equity of 14.56%. The firm had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same period last year, the firm posted $1.78 EPS. Intuitive Surgical’s quarterly revenue was up 21.4% compared to the same quarter last year. As a group, sell-side analysts forecast that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Analyst Ratings Changes

ISRG has been the subject of several research analyst reports. Erste Group Bank reissued a “hold” rating on shares of Intuitive Surgical in a research report on Wednesday, July 23rd. Wall Street Zen raised Intuitive Surgical from a “hold” rating to a “buy” rating in a report on Saturday, July 26th. Citigroup reaffirmed a “buy” rating and set a $650.00 target price (up previously from $590.00) on shares of Intuitive Surgical in a report on Thursday, May 22nd. Truist Financial boosted their price target on Intuitive Surgical from $590.00 to $600.00 and gave the company a “buy” rating in a report on Wednesday, July 23rd. Finally, Deutsche Bank Aktiengesellschaft reissued a “sell” rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Thirteen research analysts have rated the stock with a Buy rating, six have given a Hold rating and one has issued a Sell rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $595.95.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.